Tumor necrosis factor data

IMNX's TNF receptor fused to the human IgG1 Fc portion was effective in patients with rheumatoid arthritis, without toxicities.

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE